Crystalline forms of dihydropyrimidine derivatives

The present invention relates to crystalline forms of dihydropyrimidine derivatives, and pharmaceutical compositions comprising the crystalline forms disclosed herein, which may be used for preventing, managing, treating or lessening the severity of a viral disease in a patient, especially hepatitis...

Full description

Saved in:
Bibliographic Details
Main Authors Goldmann Siegfried, Zhang Yingjun, Liu Xinchang, Ren Qingyun, Wang Chaolei, Wang Tianming
Format Patent
LanguageEnglish
Published 02.08.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to crystalline forms of dihydropyrimidine derivatives, and pharmaceutical compositions comprising the crystalline forms disclosed herein, which may be used for preventing, managing, treating or lessening the severity of a viral disease in a patient, especially hepatitis B infection or a disease caused by hepatitis B infection.
Bibliography:Application Number: US201314420666